Genomic alterations in sporadic synchronous primary breast cancer using array and metaphase comparative genomic hybridization

Neoplasia

Volumn 9, Issue 6, 2007, Pages 511-520

  Ghazani, Arezou A ^a,b   Arneson, Nona ^b   Warren, Keisha ^b   Pintilie, Melania ^b   Bayani, Jane ^b   Squire, Jeremy A ^a,b   Done, Susan J ^a,b,c  

^a UNIVERSITY OF TORONTO   (Canada)

^b PRINCESS MARGARET HOSPITAL   (Canada)

^c UNIVERSITY HEALTH NETWORK   (Canada)

Author keywords

Array CGH (aCGH); Comparative genomic hybridization (CGH); Metaphase CGH (mCGH); Microdissection; Synchronous breast cancer

Indexed keywords

ARRAY COMPARATIVE GENOMIC HYBRIDIZATION; ARTICLE; BREAST CANCER; CANCER PATIENT; CHROMOSOME 11Q; CHROMOSOME 12Q; CHROMOSOME 16Q; CHROMOSOME 17P; CHROMOSOME 1Q; CHROMOSOME 3P; CHROMOSOME 4Q; CHROMOSOME 8Q; CHROMOSOME ANALYSIS; CHROMOSOME LOSS; CLINICAL ARTICLE; COMPARATIVE GENOMIC HYBRIDIZATION; CONTROLLED STUDY; GENE AMPLIFICATION; GENE IDENTIFICATION; GENE MUTATION; GENETIC ANALYSIS; HUMAN; HUMAN CELL; HUMAN TISSUE; MALE; MARKER GENE; METAPHASE COMPARATIVE GENOMIC HYBRIDIZATION; MULTIPLE CANCER; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION;

EID: 34250792728     PISSN: 15228002     EISSN: 14765586     Source Type: Journal    
DOI: 10.1593/neo.07301     Document Type: Article

References (46)

1. Tinnemans JG, Wobbes T, van der Sluis RF, Lubbers EJ, and de Boer HH (1986). Multicentricity in nonpalpable breast carcinoma and its implications for treatment. Am J Surg 151 (3), 334-338.
2. Kollias J, Pinder SE, Denley HE, Ellis IO, Wencyk P, Bell JA, Elston CW, and Blamey RW (2004). Phenotypic similarities in bilateral breast cancer. Breast Cancer Res Treat 85 (3), 255-261.
3. Teixeira MR, Pandis N, Bardi G, Andersen JA, Mandahl N, Mitelman F, and Heim S (1994). Cytogenetic analysis of multifocal breast carcinomas: detection of karyotypically unrelated clones as well as clonal similarities between tumour foci. Br J Cancer 70 (5), 922-927.
4. Pandis N, Teixeira MR, Gerdes AM, Limon J, Bardi G, Andersen JA, Idvall I, Mandahl N, Mitelman F, and Heim S (1995). Chromosome abnormalities in bilateral breast carcinomas. Cytogenetic evaluation of the clonal origin of multiple primary tumors. Cancer 76 (2), 250-258.
5. Teixeira MR, Pandis N, Bardi G, Andersen JA, and Heim S (1996). Karyotypic comparisons of multiple tumorous and macroscopically normal surrounding tissue samples from patients with breast cancer. Cancer Res 56 (4), 855-859.
6. Teixeira MR, Pandis N, Bardi G, Andersen JA, Bohler PJ, Qvist H, and Heim S (1997). Discrimination between multicentric and multifocal breast carcinoma by cytogenetic investigation of macroscopically distinct ipsilateral lesions. Genes Chromosomes Cancer 18 (3), 170-174.
7. Teixeira MR, Ribeiro FR, Torres L, Pandis N, Andersen JA, Lothe RA, and Heim S (2004). Assessment of clonal relationships in ipsilateral and bilateral multiple breast carcinomas by comparative genomic hybridisation and hierarchical clustering analysis. Br J Cancer 91 (4), 775-782.
8. Noguchi S, Aihara T, Koyama H, Motomura K, Inaji H, and Imaoka S (1994). Discrimination between multicentric and multifocal carcinomas of the breast through clonal analysis. Cancer 74 (3), 872-877.
9. Tsuda H and Hirohashi S (1995). Identification of multiple breast cancers of multicentric origin by histological observations and distribution of allele loss on chromosome 16q. Cancer Res 55 (15), 3395-3398.
10. Shibata A, Tsai YC, Press MF, Henderson BE, Jones PA, and Ross RK (1996). Clonal analysis of bilateral breast cancer. Clin Cancer Res 2 (4), 743-748.
11. Tse GM, Kung FY, Chan AB, Law BK, Chang AR, and Lo KW (2003). Clonal analysis of bilateral mammary carcinomas by clinical evaluation and partial allelotyping. Am J Clin Pathol 120 (2), 168-174.
12. Unger MA, Rishi M, Clemmer VB, Hartman JL, Keiper EA, Greshock JD, Chodosh LA, Liebman MN, and Weber BL (2001). Characterization of adjacent breast tumors using oligonucleotide microarrays. Breast Cancer Res 3 (5), 336-341.
13. Kallioniemi A, Kallioniemi OP, Sudar D, Rutovitz D, Gray JW, Waldman F, and Pinkel D (1992). Comparative genomic hybridization for molecular cytogenetic analysis of solid tumors. Science 258 (5083), 818-821.
14. Albertson DG (2003). Profiling breast cancer by array CGH. Breast Cancer Res Treat 78 (3), 289-298.
15. Bashyam M, Ryan B, Young K, Wang P, Hernandez-Boussard T, Karikari C, Tibshirani R, Maitra A, and Pollack JR (2005). Array-based comparative genomic hybridization identifies localized DNA amplifications and homozygous deletions in pancreatic cancer. Neoplasia 7, 556-562.
16. Ghazani AA, Arneson NC, Warren K, and Done SJ (2006). Limited tissue fixation times and whole genomic amplification do not impact array CGH profiles. J Clin Pathol 59 (3), 311-315.
17. Stoecklein NH, Erbersdobler A, Schmidt-Kittler O, Diebold J, Schardt JA, Izbicki JR, and Klein CA (2002). SCOMP is superior to degenerated oligonucleotide primed-polymerase chain reaction for global amplification of minute amounts of DNA from microdissected archival tissue samples. Am J Pathol 161 (1), 43-51.
18. Dracopoli NC (2000). Current Protocols in Human Genetics. John Wiley and Sons, Inc., New York, NY.
19. Speicher MR, du Manoir S, Schrock E, Holtgreve-Grez H, Schoell B, Lengauer C, Cremer T, and Ried T (1993). Molecular cytogenetic analysis of formalin-fixed, paraffin-embedded solid tumors by comparative genomic hybridization after universal DNA-amplification. Hum Mol Genet 2 (11), 1907-1914.
20. Beheshti B, Braude I, Marrano P, Thorner P, Zielenska M, and Squire JA (2003). Chromosomal localization of DNA amplifications in neuroblastoma tumors using cDNA microarray comparative genomic hybridization. Neoplasia 5 (1), 53-62.
21. Baudis M and Cleary ML (2001). Progenetix.net: an online repository for molecular cytogenetic aberration data. Bioinformatics 17 (12), 1228-1229.
22. Chunder N, Roy A, Roychoudhury S, and Panda CK (2004). Molecular study of clonality in multifocal and bilateral breast tumors. Pathol Res Pract 200 (10), 735-741.
23. Dawson PJ, Baekey PA, and Clark RA (1995). Mechanisms of multifocal breast cancer: an immunocytochemical study. Hum Pathol 26 (9), 965-969.
24. Tuck AB, O'Malley FP, Singhal H, Tonkin KS, Harris JF, Bautista D, and Chambers AF (1997). Osteopontin and p53 expression are associated with tumor progression in a case of synchronous, bilateral, invasive mammary carcinomas. Arch Pathol Lab Med 121 (6), 578-584.
25. Agelopoulos K, Tidow N, Korsching E, Voss R, Hinrichs B, Brandt B, Boecker W, and Buerger H (2003). Molecular cytogenetic investigations of synchronous bilateral breast cancer. J Clin Pathol 56 (9), 660-665.
26. James LA, Mitchell EL, Menasce L, and Varley JM (1997). Comparative genomic hybridisation of ductal carcinoma in situ of the breast: identification of regions of DNA amplification and deletion in common with invasive breast carcinoma. Oncogene 14 (9), 1059-1065.
27. Buerger H, Otterbach F, Simon R, Poremba C, Diallo R, Decker T, Riethdorf L, Brinkschmidt C, Dockhorn-Dworniczak B, and Boecker W (1999). Comparative genomic hybridization of ductal carcinoma in situ of the breast - evidence of multiple genetic pathways. J Pathol 187 (4), 396-402.
28. Yamauchi T, Ueki K, Tobe K, Tamemoto H, Sekine N, Wada M, Honjo M, Takahashi M, Takahashi T, Hirai H, et al. (1998). Growth hormone-induced tyrosine phosphorylation of EGF receptor as an essential element leading to MAP kinase activation and gene expression. Endocr J Suppl 45, S27-S31.
29. Caraglia M, Marra M, Pelaia G, Maselli R, Caputi M, Marsico SA, and Abbruzzese A (2005). Alpha-interferon and its effects on signal transduction pathways. J Cell Physiol 202 (2), 323-335.
30. Horvath CM (2004). The JAK-STAT pathway stimulated by interleukin 6. Sci STKE 2004 (260), tr9.
31. Connett JM, Hunt SR, Hickerson SM, Wu SJ, and Doherty GM (2003). Localization of IFN-gamma-activated Stat1 and IFN regulatory factors 1 and 2 in breast cancer cells. J Interferon Cytokine Res 23 (11), 621-630.
32. Kozlowski L, Zakrzewska I, Tokajuk P, and Wojtukiewicz MZ (2003). Concentration of interleukin-6 (IL-6), interleukin-8 (IL-8) and interleukin-10 (IL-10) in blood serum of breast cancer patients. Rocz Akad Med Bialymst 48, 82-84.
33. Lemmon MA (2003). The EGF receptor family as therapeutic targets in breast cancer. Breast Dis 18, 33-43.
34. Saha A, Bairwa NK, Ranjan A, Gupta V, and Bamezai R (2003). Two novel somatic mutations in the human interleukin 6 promoter region in a patient with sporadic breast cancer. Eur J Immunogenet 30 (6), 397-400.
35. Chin YE, Kitagawa M, Kuida K, Flavell RA, and Fu XY (1997). Activation of the STAT signaling pathway can cause expression of caspase 1 and apoptosis. Mol Cell Biol 17 (9), 5328-5337.
36. Meric F, Lee WP, Sahin A, Zhang H, Kung HJ, and Hung MC (2002). Expression profile of tyrosine kinases in breast cancer. Clin Cancer Res 8 (2), 361-367.
37. Welcsh PL, Lee MK, Gonzalez-Hernandez RM, Black DJ, Mahadevappa M, Swisher EM, Warrington JA, and King MC (2002). BRCA1 transcriptionally regulates genes involved in breast tumorigenesis. Proc Natl Acad Sci USA 99 (11), 7560-7565.
38. Gao B, Shen X, Kunos G, Meng Q, Goldberg ID, Rosen EM, and Fan S (2001). Constitutive activation of JAK-STAT3 signaling by BRCA1 in human prostate cancer cells. FEBS Lett 488 (3), 179-184.
39. Deng G, Lu Y, Zlotnikov G, Thor AD, and Smith HS (1996). Loss of heterozygosity in normal tissue adjacent to breast carcinomas. Science 274 (5295), 2057-2059.
40. Li Y and Rosen JM (2005). Stem/progenitor cells in mouse mammary gland development and breast cancer. J Mammary Gland Biol Neoplasia 10 (1), 17-24.
41. Chang JC, Hilsenbeck SG, and Fuqua SA (2005). The promise of microarrays in the management and treatment of breast cancer. Breast Cancer Res 7 (3), 100-104.
42. Fuqua SA, Chang JC, and Hilsenbeck SG (2004). Genomic approaches to understanding and treating breast cancer. Breast Dis 19, 35-46.
43. Wicha MS, Liu S, and Dontu G (2006). Cancer stem cells: an old idea - a paradigm shift. Cancer Res 66 (4), 1883-1890 (discussion, 1895-1896).
44. Janschek E, Kandioler-Eckersberger D, Ludwig C, Kappel S, Wolf B, Taucher S, Rudas M, Gnant M, and Jakesz R (2001). Contralateral breast cancer: molecular differentiation between metastasis and second primary cancer. Breast Cancer Res Treat 67 (1), 1-8.
45. Schlechter BL, Yang Q, Larson PS, Golubeva A, Blanchard RA, de las Morenas A, and Rosenberg CL (2004). Quantitative DNA fingerprinting may distinguish new primary breast cancer from disease recurrence. J Clin Oncol 22 (10), 1830-1838.
46. Simpson PT, Reis-Filho JS, Gale T, and Lakhani SR (2005). Molecular evolution of breast cancer. J Pathol 205 (2), 248-254.